Available at: From this enormous dataset, the team isolated over 500,000 individuals who had no prior record of hair loss but were undergoing treatment with one of six GLP1 medications: liraglutide, semaglutide, dulaglutide, exenatide, lixisenatide, or tirzepatide
3a), suggesting that the glucose-lowering effect is independent of weight loss
Tirzepatide is ideal for women who are looking for a medically supervised approach to weight loss, especially if they have struggled with traditional methods like diet and exercise alone
Tart cherries are really high in it as well
Conclusion: GLP-1 RAs significantly improve key biomarkers of systemic inflammation (CRP, TNF-) in patients with T2D compared to various active comparators and placebo